LORUSSO, BRUNO
 Distribuzione geografica
Continente #
NA - Nord America 2.576
AS - Asia 2.118
EU - Europa 1.767
SA - Sud America 284
AF - Africa 124
Continente sconosciuto - Info sul continente non disponibili 84
OC - Oceania 6
Totale 6.959
Nazione #
US - Stati Uniti d'America 2.482
IT - Italia 755
SG - Singapore 615
CN - Cina 477
VN - Vietnam 405
BR - Brasile 208
BD - Bangladesh 199
IE - Irlanda 190
HK - Hong Kong 159
DE - Germania 151
SE - Svezia 132
FR - Francia 94
ZA - Sudafrica 74
GB - Regno Unito 69
NL - Olanda 68
AT - Austria 62
IN - India 62
FI - Finlandia 58
CA - Canada 50
RU - Federazione Russa 49
TR - Turchia 29
AR - Argentina 27
JP - Giappone 25
IQ - Iraq 23
PL - Polonia 23
MX - Messico 22
BE - Belgio 21
CZ - Repubblica Ceca 21
PH - Filippine 19
CI - Costa d'Avorio 18
KR - Corea 17
EC - Ecuador 16
ES - Italia 15
PK - Pakistan 15
UA - Ucraina 15
CO - Colombia 10
IR - Iran 10
TH - Thailandia 10
ID - Indonesia 8
LT - Lituania 8
MA - Marocco 8
TN - Tunisia 8
VE - Venezuela 8
SA - Arabia Saudita 7
AU - Australia 6
EG - Egitto 6
JM - Giamaica 6
RO - Romania 6
AZ - Azerbaigian 5
GR - Grecia 5
LU - Lussemburgo 5
PY - Paraguay 5
UY - Uruguay 5
UZ - Uzbekistan 5
IL - Israele 4
JO - Giordania 4
BG - Bulgaria 3
CR - Costa Rica 3
HN - Honduras 3
KE - Kenya 3
MY - Malesia 3
PE - Perù 3
RS - Serbia 3
TW - Taiwan 3
BB - Barbados 2
CH - Svizzera 2
HR - Croazia 2
KH - Cambogia 2
KZ - Kazakistan 2
MD - Moldavia 2
NI - Nicaragua 2
NP - Nepal 2
OM - Oman 2
SV - El Salvador 2
AE - Emirati Arabi Uniti 1
BA - Bosnia-Erzegovina 1
BO - Bolivia 1
BY - Bielorussia 1
CG - Congo 1
CL - Cile 1
CY - Cipro 1
DO - Repubblica Dominicana 1
DZ - Algeria 1
EE - Estonia 1
ET - Etiopia 1
GH - Ghana 1
GP - Guadalupe 1
GT - Guatemala 1
HU - Ungheria 1
LA - Repubblica Popolare Democratica del Laos 1
LB - Libano 1
LV - Lettonia 1
MT - Malta 1
MU - Mauritius 1
NG - Nigeria 1
NO - Norvegia 1
PA - Panama 1
PS - Palestinian Territory 1
SK - Slovacchia (Repubblica Slovacca) 1
SN - Senegal 1
Totale 6.874
Città #
Ashburn 401
Singapore 369
Dallas 327
San Jose 240
Parma 191
Dublin 190
Chandler 159
Santa Clara 150
Hong Kong 144
Ho Chi Minh City 123
Boardman 107
Hanoi 89
New York 86
Beijing 81
Council Bluffs 81
Munich 77
Johannesburg 68
Los Angeles 68
Milan 67
Bologna 61
Ann Arbor 55
Vienna 54
Shanghai 47
Lauterbourg 44
Hefei 35
Buffalo 34
Dearborn 31
Helsinki 25
Rome 25
Chicago 22
Frankfurt am Main 22
Moscow 22
Nanjing 22
Amsterdam 21
Bremen 20
São Paulo 20
Turku 20
Brussels 19
Reggio Emilia 19
Verona 19
Abidjan 18
Atlanta 18
Haiphong 18
Toronto 18
Tokyo 17
Princeton 16
Warsaw 16
Izmir 15
London 15
Montreal 15
Brooklyn 14
Modena 14
Baghdad 12
Da Nang 12
Nanchang 12
Seattle 12
Nuremberg 11
Rio Saliceto 11
Seoul 11
Brescia 10
Columbus 10
Lahore 10
West Jordan 10
Brno 9
Carpi 9
Chongqing 9
Denver 9
Olomouc 9
Phoenix 9
Redondo Beach 9
The Dalles 9
Trento 9
Florence 8
Fremont 8
Guangzhou 8
Hebei 8
Houston 8
Marseille 8
Mumbai 8
Pune 8
Rio de Janeiro 8
Wilmington 8
Charlotte 7
Orem 7
Poplar 7
Bari 6
Curitiba 6
Fidenza 6
Jinan 6
Kyiv 6
Mexico City 6
Stockholm 6
Zhengzhou 6
Baku 5
Belo Horizonte 5
Bengaluru 5
Biên Hòa 5
Bolzano 5
Boston 5
Changsha 5
Totale 4.235
Nome #
238P Exploring blood immune cell dynamics to unravel the immunomodulatory effect of radiotherapy in NSCLC patients undergoing immune checkpoint inhibitors 247
Identification of an Epi-metabolic dependency on EHMT2/G9a in T-cell acute lymphoblastic leukemia 231
1328P Dynamic blood immune-inflammatory and radiomic profiling to decode distinct patterns of acquired resistance to immunotherapy in NSCLC patients 220
Validation of a radiomic approach to decipher NSCLC immune microenvironment in surgically resected patients 216
Low PD-1 expression in Cytotoxic CD8+ Tumor infiltrating Lymphocytes Confers an Immune Privileged Tissue Microenvironment in NSCLC with a Prognostic and Predictive Value 207
227P Sexual dimorphism in immune profile of early and advanced NSCLC 205
INTEGRATION OF TISSUE PD-1/PD-L1 IMMUNE CHECKPOINT WITH COMPUTED TOMOGRAPHY (CT) BASED TEXTURE ANALYSIS EXHIBITS HIGH PROGNOSTIC IMPACE ON SURGICALLY RESECTED NON SMALL CELL LUNG CANCER (NSCLC) 197
Blood and lymphatic vessels contribute to the impact of the immune microenvironment on clinical outcome in non-small-cell lung cancer 195
Dynamic Profiling of Blood Immunophenotypes and Radiomic Features to Predict Immunotherapy Response in Advanced Non-small Cell Lung Cancer 190
Genetics of Darier’s Disease: New Insights into Pathogenic Mechanisms 190
LONGITUDINAL MONITORING OF RADIOMIC AND BLOOD IMMUNE-INFLAMMATORY DESCRIPTORS AS A NON-INVASIVE APPROACH TO PREDICT ICI EFFICACY IN ADVANCED NSCLC PATIENTS 189
MESENCHYMAL STROMAL CELLS ISOLATED FROM DEFINED NSCLC CONTEXTURES REPRODUCE THE IMMUNE SIGNATURE OF THE PARENTAL MICROENVIRONMENT 186
189P The parallel interrogation of tissue and peripheral blood immune features unveils a bidirectional crosstalk with clinical impact on resected NSCLC 179
Dataset on the identification of a prognostic radio-immune signature in surgically resected Non Small Cell Lung Cancer 176
In Vitro Biological and Functional Properties of Human Endothelial Cells from Different Sources Exposed to Different Beta-Blockers 172
BLOOD AND LYMPHATIC VESSELS CONSTITUTE AN ESSENTIAL COMPONENT OF THE IMMUNE MICROENVIRONMENT AND ITS IMPACT ON NON SMALL CELL LUNG CANCER (NSCLC) CLINICAL OUTCOME 171
2315P Clinical and blood immune-inflammatory profiling to decode different patterns of acquired resistance in immunotherapy treated NSCLC patients 167
Integrated MRI–Immune–Genomic Features Enclose a Risk Stratification Model in Patients Affected by Glioblastoma 165
Lung mesenchymal cells function as an inductive microenvironment for human lung cancer propagating cells† 165
Isolation and characterization of human lung lymphatic endothelial cells 162
Assessment of Cardiac Patches Suitability for Tissue Engineering 162
CAD204520 Targets NOTCH1 PEST Domain Mutations in Lymphoproliferative Disorders 161
Dynamic evolution of blood immune-inflammatory descriptors in advanced non-small cell lung cancer undergoing first-line immunotherapy-based regimens 161
Identification of the Atypical Protein Kinase WNK1 As a New Target in T-Cell Acute Lymphoblastic Leukemia 160
Structural and Functional Characterization of the Hemolymphangiogenic Microenvironment in Lung Cancer 157
Integrated CT imaging and tissue immune features disclose a radio-immune signature with high prognostic impact on surgically resected NSCLC 156
Longitudinal blood immune-inflammatory and radiomic profiling to decode different patterns acquired resistance to immunotherapy in patients with NSCLC 152
Orthogonal proteogenomic analysis identifies the druggable PA2G4-MYC axis in 3q26 AML 149
Differential Pattern of Myocardial Remodelling in Genetically Determined and Load- Dependent Hypertrophy in Humans 146
P1.15-04 Dynamic Profiling of Blood Immunophenotypes and Radiomic Features to Predict Immunotherapy Response in Advanced Non-small Cell Lung Cancer 144
Orthogonal Proteogenomic Approaches Identify the Druggable PA2G4-MYC Axis in 3q26 AML 140
5P Blood immune-inflammatory dynamic unveils distinctive irAE features in ICI treated NSCLC 137
Differential Tumorigenic Properties of Mesenchymal Cells From Neoplastic and Non-Neoplastic Human Lung in NSCLC 134
The Atypical Protein Kinase WNK1 Controls Leukemia Progression in TAL/LMO T-Cell Acute Lymphoblastic Leukemia 133
1061P Static and dynamic tracking of radiomic and immunophenotypic features predicts the benefit of immune checkpoint inhibitors in advanced NSCLC 133
CD26 is differentially expressed throughout the life cycle of infantile hemangiomas and characterizes the proliferative phase 132
Β-blockers activate autophagy on infantile hemangioma-derived endothelial cells in vitro 129
IMPACT OF THE TISSUE DISTRIBUTION OF SUBPOPULATIONS OF TILS AND PD-L1 EXPRESSION ON THE CLINICAL OUTCOME OF NSCLC 128
Deciphering the different patterns of acquired resistance in immunotherapy treated NSCLC patients through an integrated clinical and blood immuneinflammatory profiling 125
Advanced CT imaging features reflect distinct tissue immune profiles and exhibit high prognostic impact on NSCLC 115
Divergent PD-1 expression in tissue and circulating CD8 lymphocytes defines an immune profile predictive of the response to nivolumab in advanced NSCLC 110
Deciphering multifaceted connections between NOTCH1 and SERCA2 proteins in the Darier's disease: a paradigmatic molecular network in the pathogenesis of a Mendelian genodermatosis 64
EHMT2/G9A drives the epigenetic regulation of glucose metabolism in T-cell Acute lymphoblastic leukemia 61
Inhibition of the Atypical Kinase WNK1 as a Therapeutic Strategy in TAL-related T-cell Acute Lymphoblastic Leukemia 20
PYGO2 is overexpressed in multiple myeloma patients with 1q21 amplification, driving plasma cell proliferation and cell cycle progression 20
Totale 6.959
Categoria #
all - tutte 22.984
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 22.984


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2021/202283 0 5 2 6 1 4 15 7 2 5 4 32
2022/2023767 58 70 40 71 110 72 26 45 214 7 39 15
2023/2024510 24 22 21 26 50 72 83 20 31 48 29 84
2024/20251.247 63 64 92 112 113 82 105 74 116 102 109 215
2025/20263.645 288 227 547 361 385 211 298 160 509 269 231 159
2026/2027264 119 145 0 0 0 0 0 0 0 0 0 0
Totale 6.959